CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Qrons Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Qrons Inc
28-10 JACKSON AVENUE, #26N
Phone: (212) 945-2080p:212 945-2080 LONG ISLAND CITY, NY  11101  United States Ticker: QRONQRON

Business Summary
Qrons Inc. is a biotechnology company. The Company is focused on developing biotech products, treatments, and technologies that create a platform to combat neuronal diseases. It leverages its research with developing technologies in the fields of artificial intelligence (AI), machine learning (ML), molecular biology, stem cells, and tissue engineering for deployment in the fight against neuronal diseases. The Company has developed two product candidates for treating penetrating and non-penetrating (concussion-like) traumatic brain injuries (TBIs), both integrating proprietary anti-brain inflammation synthetic hydrogel and modified mesenchymal stem cells (MSCs). Its QS100TM is an injury-specific, 3D printable, implantable MSCs-synthetic hydrogel to treat penetrating brain injuries, such as gunshot wounds, motor vehicle accidents, and falls. Its QS200TM is an injectable MSCs-synthetic hydrogel for the treatment of diffused axonal injuries commonly referred to as concussions.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Chief Financial Officer, Secretary & Director JonahMeer
Chief Executive Officer, Chief Financial Officer, Secretary & Director JonahMeer
President & Director IdoMerfeld
President & Director IdoMerfeld

General Information
Number of Employees: 2 (As of 12/31/2022)
Outstanding Shares: 13,589,789 (As of 11/10/2023)
Shareholders: 37
Stock Exchange: OTC
Federal Tax Id: 813623646


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024